CARA THERAPEUTICS INC's ticker is CARA and the CUSIP is 140755109. A total of 183 filers reported holding CARA THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.22 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $156,435 | -71.1% | 93,116 | -51.2% | 0.00% | -66.7% |
| Q2 2023 | $540,499 | +82418.9% | 190,989 | +43.1% | 0.01% | -40.0% |
| Q1 2023 | $655 | -99.9% | 133,431 | -0.1% | 0.01% | -63.0% |
| Q3 2022 | $1,251,000 | +44.0% | 133,603 | +40.4% | 0.03% | +17.4% |
| Q2 2022 | $869,000 | -16.0% | 95,168 | +31.3% | 0.02% | +15.0% |
| Q2 2021 | $1,035,000 | +275.0% | 72,497 | +234.6% | 0.02% | +66.7% |
| Q3 2020 | $276,000 | -79.6% | 21,666 | -70.6% | 0.01% | -71.4% |
| Q1 2017 | $1,354,000 | +1201.9% | 73,635 | +490.9% | 0.04% | +2000.0% |
| Q3 2016 | $104,000 | -51.6% | 12,461 | -72.2% | 0.00% | -60.0% |
| Q2 2016 | $215,000 | -56.7% | 44,763 | -44.0% | 0.01% | -61.5% |
| Q1 2016 | $497,000 | +146.0% | 79,875 | +567.9% | 0.01% | +116.7% |
| Q4 2015 | $202,000 | -9.4% | 11,959 | -23.3% | 0.01% | -25.0% |
| Q3 2015 | $223,000 | – | 15,584 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 2,204,449 | $10,824 | 1.35% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 1,233,000 | $6,054,030 | 1.14% |
| Chescapmanager LLC | 1,160,392 | $5,698 | 0.90% |
| DISCIPLINED GROWTH INVESTORS INC /MN | 1,732,375 | $8,505,961 | 0.22% |
| XTX Topco Ltd | 107,610 | $528,365 | 0.11% |
| IQ EQ FUND MANAGEMENT (IRELAND) Ltd | 84,530 | $415,042 | 0.08% |
| PINNACLE ASSOCIATES LTD | 679,413 | $3,335,918 | 0.07% |
| PDT Partners, LLC | 102,010 | $500,869 | 0.07% |
| FARALLON CAPITAL MANAGEMENT LLC | 1,995,370 | $9,797,267 | 0.05% |
| AXQ CAPITAL, LP | 27,760 | $136,302 | 0.05% |